Back

The prognostic value of metabolic dysfunction associated steatotic liver disease in acute myocardial infarction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New considerations in acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Gwyneth Kong

National University Health System, Singapore (Singapore)

8 More presentations in this session

Presentation thumbnail
Pre-discharge prediction of long-term prognosis in patients after ST-segment elevation myocardial infarction - the ValAMI-P risk score
Doctor H. Merenciano Gonzalez (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
An examination of co-existence of metabolic dysfunction-associated liver disease and chronic kidney disease and its effect on long-term mortality in patients with acute myocardial infarction
Doctor A. Zhang (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland
Doctor A. Bularga (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Iron deficiency and all-cause mortality after myocardial infarction
Doctor D. Jenca (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Coronary heart disease: leading cause of cardiovascular death from analysis of autopsies in a central european university centre
Associate Professor J. Petrkova (Olomouc, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
New considerations in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
An examination of co-existence of metabolic dysfunction-associated liver disease and chronic kidney disease and its effect on long-term mortality in patients with acute myocardial infarction
thumbnail
Congress Presentation
Cardiovascular-kidney-liver-metabolic-health:a population-based study on the prognostic impact of the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease
thumbnail
Congress Presentation
Incremental prognostic value of metabolic dysfunction-associated fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources